Atlas Trials

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC

Clinical trial NCT01263002 · COMPLETED

Trial details

NCT number
NCT01263002
Sponsor
Bukwang Pharmaceutical
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B Associated Hepatocellular Carcinoma
Start date
2010-06-01
Primary completion
2013-01-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.